Showing results (1431-1440 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|October 31, 2019
Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing SpondylitisJessica A Walsh, Shaobo Pei, Gopi K Penmetsa, et al.Journal of Managed Care & Specialty Pharmacy|August 29, 2020
Limited Generalizability of a Retrospective Chart Review Comparing 3 Recombinant FVIII Products for Hemophilia A ProphylaxisRonald Preblick, Cori Gray, Talaha Ali, et al.Journal of Managed Care & Specialty Pharmacy|August 29, 2020
The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims DatabaseElizabeth L Eby, Sanjay Bajpai, Douglas E Faries, et al.Journal of Managed Care & Specialty Pharmacy|August 29, 2020
ICER's Version of HTA Is Positioned to Guide U.S. Health Care ReformJohn B WatkinsJournal of Managed Care & Specialty Pharmacy|August 29, 2020
The Authors RespondMindy L Simpson, Vidhi Desai, Géraldine S Maro, et al.Journal of Managed Care & Specialty Pharmacy|September 30, 2020
Perceptions of the Value of Clinical Pharmacy Medication Review for Women During Early PregnancyMinna Lee, Deanna Kurz, Sarah Schwiesow, et al.Journal of Managed Care & Specialty Pharmacy|September 30, 2020
Managed Care Pharmacy Research on Inappropriate Opioid Use InterventionsLt Lauren Hertzog, Carrie McAdam-Marx, Laura E HappeJournal of Managed Care & Specialty Pharmacy|September 30, 2020
Direct Costs of Opioid Abuse in an Insured Population in the United StatesAlan G White, Howard G Birnbaum, Milena N Mareva, et al.Journal of Managed Care & Specialty Pharmacy|September 30, 2020
Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral RegionChanadda Chinthammit, Sandipan Bhattacharjee, David R Axon, et al.Journal of Managed Care & Specialty Pharmacy|April 1, 2020
The Inclusion of Economic Endpoints as Outcomes in Clinical Trials Reported to ClinicalTrials.govJordan M Mitchell, Julie A PattersonPageof 185